ONCY - Oncolytics Biotech GAAP EPS of -$0.10 in-line May, 05 2023 12:57 PM Oncolytics Biotech Inc. 2023-05-05 12:57:59 ET Oncolytics Biotech press release ( NASDAQ: ONCY ): Q1 GAAP EPS of -$0.10 in-line. $29.7 million in cash, cash equivalents, and marketable securities as of March 31, 2023 provides projected cash runway for at least 12 months. Shares +11% . For further details see: Oncolytics Biotech GAAP EPS of -$0.10 in-line